Emma Walmsley was the first woman to hold the CEO post at the Big Pharma company.

Outgoing CEO Walmsley's bold R&D push ignites investor buzz as AstraZeneca and GSK shares jump on deal optimism ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks. Read more here.

M&A headlined for a second straight week as Genmab acquired Merus for $8 billion; Pfizer strikes most-favored-nation deal ...

Stocks closed higher Monday, rebounding after a losing week, but the dollar and Treasury yields fell on fears of a possible ...

Eleven stocks were on a high note on Tuesday, dominated by US pharmaceutical companies, as investors began loading portfolios ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Shares were mostly higher Monday in Asia after Wall Street broke its three-day losing streak, trimming its losses for last week. China factory data are due out on Tuesday and a quarterly business ...

The pharmaceutical industry is witnessing significant leadership changes and strategic decisions. GSK's Emma Walmsley steps down for Luke Miels, AstraZeneca plans a US share listing, CSL appoints Ken ...

AstraZeneca is delisting its American Depositary Receipts from the Nasdaq, replacing them with a direct listing of ordinary shares on the New York Stock Exchange. At first blush, it confirms fears ...

GSK CEO Emma Walmsley will step down in 2025, with Luke Miels taking over as the company refocuses on pipeline growth and Montco operations.

Nike on Tuesday reported a surprise rise in first-quarter revenue and beat profit expectations as the storied sportswear brand's turnaround effort gained traction despite weakness in China and tariffs ...